Latest news

• Moderna’s COVID-19 vaccine could offer protection for ‘a couple of years’, says CEO

  On Wednesday, the European Commission granted Moderna’s COVID-19 vaccine, initially called mRNA-1273, a conditional marketing authorisation to prevent the disease in people aged 18 years and older.

• EMA recommends authorisation of Moderna’s COVID-19 vaccine

  The EMA’s Committee for Medicinal Products for Human Use (CHMP) met to discuss the Moderna vaccine, mRNA-1273, on Monday. ... older. Following this recommendation, the European Commission (EC) is likely to grant mRNA-1273 a formal conditional marketing

• Moderna wins EU authorisation for COVID-19 vaccine

  Moderna’s European manufacturing partner Lonza received authorisation from Swiss regulators last week to begin producing mRNA-1273 at its plant in Switzerland.

• Moderna could potentially deliver one billion COVID-19 vaccine doses this year

  The US government has agreed to purchase 200 million doses of mRNA-1273 with options to purchase another 300 million doses. ... The European Commission has already approved a contract for an initial 80 million doses of mRNA-1273, with a further option to

• Moderna receives FDA emergency authorisation for its COVID-19 vaccine

  Following this recommendation, the FDA has formally granted mRNA-1273 a EUA for the prevention of COVID-19 in individuals aged 18 years and older. ... Following the EUA, Moderna will now begin to deliver the first mRNA-1273 doses to the US government